Haplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups

Pharmacogenetics

Volumn 12, Issue 9, 2002, Pages 725-733

  Innocenti, Federico ^a   Grimsley, Carrie ^a   Das, Soma ^a   Ramírez, Jacqueline ^a   Cheng, Cheng ^b   Kuttab Boulos, Hala ^a   Ratain, Mark J ^a   Di Rienzo, Anna ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Haplotype; Promoter; SN 38; UGT1A1

Indexed keywords

GLUCURONOSYLTRANSFERASE; GLUCURONOSYLTRANSFERASE 1A1; UNCLASSIFIED DRUG;

ARTICLE; CAUCASIAN; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME STRUCTURE; ETHNIC GROUP; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; GLUCURONIDATION; HAPLOTYPE; HUMAN; HUMAN TISSUE; LIVER MICROSOME; NEGRO; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION;

AFRICAN AMERICANS; BASE SEQUENCE; BILIRUBIN; CAMPTOTHECIN; DNA TOPOISOMERASES, TYPE I; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOTYPE; GLUCURONIDES; GLUCURONOSYLTRANSFERASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MICROSOMES, LIVER; MOLECULAR SEQUENCE DATA; PHENOBARBITAL; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 12244271026     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200212000-00006     Document Type: Article

References (33)

1. Tukey RH, Strassburg CP. Human UDP-glucuronosyltransferases: Metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 2000; 40:581-616.
2. Beutler E, Gelbart T, Demina A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: A balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci USA 1998; 95:8170-8174.
3. Bosma PJ, Chowdhury JR, Bakker C, Gantla S, de Boer A, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 1995; 333:1171-1175.
4. Monaghan G, Ryan M, Seddon R, Hume R, Burchell B. Genetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet 1996; 347:578-581.
5. Ando Y, Saka H, Ando M, Sawa T, Muro K, Ueoka H, et al. Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: A pharmacogenetic analysis. Cancer Res 2000; 60:6921-6926.
6. Iyer L, Das S, Janish L, Wen M, Ramirez J, Karrison T, et al. UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity. Pharmacogenomics J 2002; 2:43-47.
7. Guillemette C, Millikan RC, Newman B, Housman DE. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans. Cancer Res 2000; 60:950-956.
8. Sugatani J, Kojima H, Ueda A, Kakizaki S, Yoshinari K, Gong QH, et al. The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR. Hepatology 2001; 33:1232-1238.
9. Sugatani J, Yamakawa K, Yoshinari K, Machida T, Takagi H, Mori M, et al. Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia. Biochem Biophys Res Commun 2002; 292:492-497.
10. Gupta E, Lestingi TM, Mick R, Ramirez J, Vokes EE, Ratain MJ. Metabolic fate of irinotecan in humans: Correlation of glucuronidation with diarrhea. Cancer Res 1994; 54:3723-3725.
11. Purba HS, Maggs JL, Orme ML, Back DJ, Park BK. The metabolism of 17 alpha-ethinyloestradiol by human liver microsomes: Formation of catechol and chemically reactive metabolites. Br J Clin Pharmacol 1987; 23: 447-453.
12. Ramirez J, Iyer L, Journault K, Belanger P, Innocenti F, Ratain MJ, Guillemette C. In vitro characterization of hepatic flavopiridol metabolism using human liver microsomes and recombinant UGT enzymes. Pharm Res 2002; 19:588-594.
13. Innocenti F, Iyer L, Ramirez J, Green MD, Ratain MJ. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7. Drug Metab Dispos 2001; 29:686-692.
14. Rozen S, Skaletsky HJ. Primer3. Code available at http://www-genome.wi.mit.edu/genome_software/other/primertml; 1998.
15. Nickerson DA, Tobe VO, Taylor SL. PolyPhred: Automating the detection and genotyping of single nucleotide substitutions using flourescence-based resequencing. Nucleic Acids Res 1997; 25:2745-2751.
16. Iyer L, King CD, Whitington PF, Green MD, Roy SK, Tephly TR, et al. Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes. J Clin Invest 1998; 101:847-854.
17. Schneider S, Roessli D, Excoffier L. Arelquin Version 2.000: A Software for Population Genetics Analysis. Geneva, Switzerland: Genetics and Biometry Laboratory, University of Geneva, Switzerland; 2000.
18. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68:978-989.
19. Rozas J, Rozas R. DnaSP version 3: An integrated program for molecular population genetics and molecular evolution analysis. Bioinformatics; 15:174-175.
20. Nei M. Molecular Evolutionary Genetics. New York: Columbia University Press; 1987.
21. Gibbons JD, Charkraborti S. Nonparametric Statistical Inference, 3rd Edn. New York: Marcel Dekker, Inc.; 1992.
22. Brierley CH, Senafi SB, Clarke D, Hsu MH, Johnson EF, Burchell B. Regulation of the human bilirubin UDP-glucuronosyltransferase gene. Adv Enzyme Regul 1996; 36:85-97.
23. Ueyama H, Koiwai O, Soeda Y, Sato H, Satoh Y, et al. Analysis of the promoter of human bilirubin UDP-glucuronosyltransferase gene (UGT1*1) in relevance to Gilbert's syndrome. Hepatol Res 1997; 9:152-163.
24. Iyer L, Hall D, Das S, Mortell MA, Ramirez J, Kim S, et al. Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism. Clin Pharmacol Ther 1999; 65:576-582.
25. Iolascon A, Faienza MF, Centra M, Storelli S, Zelante L, Savoia A. (TA)8 allele in the UGT1A1 gene promoter of a Caucasian with Gilbert's syndrome. Haematologica 1999; 84:106-109.
26. Tsezou A, Tzetis M, Kitsiou S, Kavazarakis E, Galla A, Kanavakis E. A Caucasian boy with Gilbert's syndrome heterozygous for the (TA)(8) allele. Haematologica 2000; 85:319.
27. Frisse L, Hudson RR, Bartoszewicz A, Wall JD, Donfack J, Di Rienzo A. Gene conversion and different population histories may explain the contrast between polymorphism and linkage disequilibrium levels. Am J Hum Genet 2001; 69:831-843.
28. Hall D, Ybazeta G, Destro-Bisol G, Petzl-Erler ML, Di Rienzo A. Variability at the uridine diphosphate glucuronosyltransferase 1A1 promoter in human populations and primates. Pharmacogenetics 1999; 9:591-599.
29. Lampe JW, Bigler J, Horner NK, Potter JD. UDP-glucuronosyltransferase (UGT1A1*28 and UGT1A6*2) polymorphisms in Caucasians and Asians: Relationships to serum bilirubin concentrations. Pharmacogenetics 1999; 9:341-349.
30. Akaba K, Kimura T, Sasaki A, Tanabe S, Ikegami T, Hashimoto M, et al. Neonatal hyperbilirubinemia and mutation of the bilirubin uridine diphosphate- glucuronosyltransferase gene: A common missense mutation among Japanese, Koreans and Chinese. Biochem Mol Biol Int 1998; 46:21-26.
31. Akaba K, Kimura T, Sasaki A, Tanabe S, Wakabayashi T, Hiroi M, et al. Neonatal hyperbilirubinemia and a common mutation of the bilirubin uridine diphosphate- glucuronosyltransferase gene in Japanese. J Hum Genet 1999; 44:22-25.
32. Huang CS, Luo GA, Huang ML, Yu SC, Yang SS. Variations of the bilirubin uridine- diphosphoglucuronosyl transferase 1A1 gene in healthy Taiwanese. Pharmacogenetics 2000; 10:539-544.
33. Maruo Y, Nishizawa K, Sato H, Doida Y, Shimada M. Association of neonatal hyperbilirubinemia with bilirubin UDP-glucuronosyltransferase polymorphism. Pediatrics 1999; 103:1224-1227.